Polymorphic ventricular tachycardia in the coronary care unit

Heart and Lung: Journal of Acute and Critical Care

Volumn 35, Issue 4, 2006, Pages 283-289

  Varriale, Philip ^a   Leonardi, Marino ^a  

^a CABRINI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; DOFETILIDE; IBUTILIDE; MAGNESIUM SULFATE; METOPROLOL; PHENOTHIAZINE; POTASSIUM CHLORIDE;

ACUTE DISEASE; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY HOSPITAL; CONTROLLED STUDY; CORONARY CARE UNIT; DEATH; DEFIBRILLATION; DISEASE SEVERITY; DRUG EFFECT; DRUG OVERDOSE; DRUG SAFETY; ELECTROCARDIOGRAM; EMERGENCY CARE; EXPERIENCE; FEMALE; FREQUENCY ANALYSIS; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; LONG QT SYNDROME; MALE; OBSERVATIONAL STUDY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QT PROLONGATION; RECURRENT DISEASE; REFRACTORY PERIOD; SYMPTOMATOLOGY; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; ANTI-ARRHYTHMIA AGENTS; CORONARY CARE UNITS; DIAGNOSIS, DIFFERENTIAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 33746094652     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2005.12.005     Document Type: Article

References (25)

1. Nguyen P.T., Scheinman M.M., and Seger J. Polymorphous ventricular tachycardia. clinical characterization, therapy, and the QT interval. Circulation 74 (1986) 340-349
2. Ben-David J., and Zipes D.P. Torsades de pointes and proarrhythmia. Lancet 341 (1993) 1578-1582
3. Schwartz P.J., Moss A.J., Vincent G.M., and Crampton R.S. Diagnostic criteria for long QT syndrome. an update. Circulation 88 (1993) 782-784
4. Keating M. Genetics of the long QT syndrome. J Cardiovasc Electrophysiol 5 (1994) 146-153
5. El-Sherif N., Chinushi M., Caref E.B., and Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of de pointes tachyarrhythmia in the long QT syndrome. Circulation 96 (1997) 4392-4399
6. Antzelevitch C., and Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. role of M cells in the generation of U waves, triggered activity and torsades de pointes. J Am Coll Cardiol 23 (1994) 259-277
7. Moss A.J. Long QT syndrome. J Am Med Assoc 289 (2003) 2041-2044
8. Roelke M., Garan H., McGovern B.A., and Ruskin J.N. Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Coll Cardiol 23 (1994) 117-122
9. Kay G.N., Plumb V.J., Arciniegas J.G., Henthorn R.W., and Waldo A.L. Torsades de pointes. the long-short initiating sequence and other clinical features. AM J Coll Cardiol 2 (1983) 806-817
10. Habbab M.A., and El-Sherif N. Drug induced torsades de pointes. Role of early afterdepolarizations and dispersion of repolarization. Am J Med 89 (1990) 241-246
11. Kurita T., Ohe T., Marui N., Alhara N., Takaki H., Kamamura S., et al. Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes. Am J Cardiol 69 (1992) 628-633
12. Goldman D.S., and Levine P.A. Pacemaker-mediated polymorphic ventricular tachycardia. Pacing Clin Electrophysiol 21 (1998) 1993-1995
13. Wolfe C.L., Nibley C., Bhandari A., Chatterjee K., and Scheinman M. Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation 84 (1991) 1543-1551
14. Leenhardt A., Glaser E., Burguera M., Numberg M., Maison-Blanche P., and Coumel P. Short-coupled variant of torsades de pointes. a new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 89 (1994) 206-215
15. Roden D.M. Drug-induced prolongation of the QT interval. N England Med 3501 (2004) 1013-1021
16. Khan M.M., Logan K.R., McComb J.M., and Adgey A.A. Management of recurrent ventricular tachyarrhythmias associated with QT prolongation. Am J Cardiol 47 (1981) 1301-1308
17. Tzivoni D., Keren A., Cohen A.M., Loebel H., Zahavi I., Chenzbraun A., et al. Magnesium therapy for torsades de pointes. Am J Cardiol 53 (1984) 528-530
18. Kaseda S., Gilmour R.F., and Zires D.P. Depressant effect of magnesium on early afterdepolarization and triggered activity induced by cesium, quinidine and 4-aminopyridine in canine cardiac purkinje fibers. Am Heart J 118 (1989) 458-463
19. Banai S., and Tzivoni D. Drug therapy for torsades de pointes. J Cardiovasc Electrophysiol 4 (1993) 206-210
20. Pinski S.I., and Fahy G.J. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 92 (1995) 1651-1664
21. Duru F., and Candinas R. Potential proarrhythmic effects of implantable defibrillators. Clin Cardiol 22 (1999) 139-146
22. Lauer M.R., Young C., Liem L.B., Ottoboni L., Peterson J., Goold P., et al. Ventricular fibrillation induced by low-energy shocks from programmable implantable cardioverter-defibrillators in patients with coronary artery disease. Am J Cardiol 73 (1994) 559-563
23. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., and Lehmann M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. J Am Med Assoc 270 (1993) 1590-1597
24. Priori S.G., Napolitano C., and Schwartz P.J. Low penetrance in the long QT syndrome. Clin Impact Circ 33 (1999) 523-533
25. Farmer D.M., Swygman C.A., Wang III P.J., and Link M.S. Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators). Am J Cardiol 91 (2003) 606-608